Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCT vs Observation in PTCL CR1
NCT06724237Phase 3Recruiting
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jun 2025
- Primary completion
- Apr 2074
- Countries
- 2
01
Overview
A Phase 3 trial of autologous hematopoietic stem cells in peripheral T-cell lymphoma (PTCL), sponsored by Eastern Cooperative Oncology Group. Started Jun 2025; status: recruiting.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT06724237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06724237.